Paushak Limited
Paushak Limited (PAUSHAKLTD): company summary
The company's annual revenue rose 3.6% to ₹219 crore, while annual net profit fell 19.7% to ₹39 crore.
Paushak Limited (PAUSHAKLTD) is a micro-cap Chemicals company valued at ₹2,046 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Paushak Limited last traded at ₹815.05, up 3.17% on the day.
- Recent developments
- On 2026-07-23, the company announced a dividend of ₹2.50 per share, with the ex-date set for that day. The company's promoter holding remained at 67.28% as of 2026-06-30, with domestic institutional holding at 0.07%.
- Financial performance
- The company's annual revenue rose 3.6% to ₹219 crore, while annual net profit fell 19.7% to ₹39 crore. The latest quarter saw revenue jump 49.2% to ₹84 crore and net profit rise 25.8% to ₹15 crore, indicating stronger performance in the most recent period compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 51.1 times earnings, 3.68 times book value. It yields 0.3%.
- Things to watch
- The company's net profit margin narrowed 5.2 percentage points to 18.0%, and annual net profit declined 19.7%. The stock is 21.3% below its 52-week high, and profit growth has slowed significantly over the past five years, with a 1.2% annual growth rate.
- Where it stands
- The company's latest quarter showed strong revenue and net profit growth, but annual figures reveal a decline in net profit and a narrowing margin. The stock is 21.3% below its 52-week high, and the company's profit growth has slowed over the past five years.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (8.0) and momentum (7.5), but held back by valuation (0.0). Risk looks strong at 8.0, but that is offset by valuation at 0.0 and growth at 2.5. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.16
- Profitable in all of the last 5 years
- Healthy net margin (18%)
- Valuation is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore Paushak Limited’s valuation
Free deep-dive tools · no sign-up
Paushak Limited peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Paushak Limited with the ratios and calculators DocStoX uses in its analysis.

